NMPA Approval

Compound Troxerutin and Poreine Cerebroside Injection

Approval Number

国药准字H22026578

Company吉林天成制药有限公司

Registration Date

August 10, 2020

Drug Information

Generic Name

复方曲肽注射液

Dosage Form

注射剂

Strength

5ml:200mg曲克芦丁,2.5mg总氮,1.5mg单唾液酸四己糖神经节苷脂(GM1)

Drug Type

化学药品

Registration Date

August 10, 2020

Company Information

Applicant Company

Company Name吉林天成制药有限公司

Manufacturing Company

Company Name吉林天成制药有限公司

Company Address

吉林省梅河口市建国路4555号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

复方曲肽注射液 - NMPA 批准文号 | MedPath